Endurant Capital Management LP - Q1 2018 holdings

$268 Million is the total value of Endurant Capital Management LP's 69 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was - .

 Value Shares↓ Weighting
UHS NewUNIVERSAL HLTH SVCS INCcl b$9,875,00083,400
+100.0%
3.69%
SYNH NewSYNEOS HEALTH INCcl a$6,830,000192,400
+100.0%
2.55%
HCA NewHCA HEALTHCARE INC$4,346,00044,800
+100.0%
1.62%
GILD NewGILEAD SCIENCES INC$3,558,00047,200
+100.0%
1.33%
MASI NewMASIMO CORP$1,838,00020,900
+100.0%
0.69%
PPH NewVANECK VECTORS ETF TRpharmaceutical$1,449,00025,500
+100.0%
0.54%
VRX NewVALEANT PHARMACEUTICALS INTL$1,356,00085,200
+100.0%
0.51%
A NewAGILENT TECHNOLOGIES INC$1,338,00020,000
+100.0%
0.50%
DGX NewQUEST DIAGNOSTICS INC$1,304,00013,000
+100.0%
0.49%
OCUL NewOCULAR THERAPEUTIX INC$1,162,000178,461
+100.0%
0.43%
ICLR NewICON PLC$992,0008,400
+100.0%
0.37%
BLCM NewBELLICUM PHARMACEUTICALS INC$947,000144,300
+100.0%
0.35%
TFX NewTELEFLEX INC$918,0003,600
+100.0%
0.34%
XRAY NewDENTSPLY SIRONA INC$664,00013,200
+100.0%
0.25%
QGEN NewQIAGEN NV$662,00020,500
+100.0%
0.25%
VKTX NewVIKING THERAPEUTICS INC$520,000119,100
+100.0%
0.19%
RETA NewREATA PHARMACEUTICALS INCcl a$513,00025,000
+100.0%
0.19%
AVDL NewAVADEL PHARMACEUTICALS PLCsponsored adr$406,00055,700
+100.0%
0.15%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LABORATORY CORP AMER HLDGS31Q2 20238.7%
ELEVANCE HEALTH INC29Q3 20238.8%
BECTON DICKINSON & CO28Q2 20239.8%
MCKESSON CORP27Q1 20234.4%
CENCORA INC26Q3 20235.9%
HOLOGIC INC24Q3 20237.5%
JOHNSON & JOHNSON24Q4 20215.5%
ZIMMER HLDGS INC23Q3 20237.5%
BOSTON SCIENTIFIC CORP22Q3 20235.5%
DAVITA INC22Q1 20214.9%

View Endurant Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Endurant Capital Management LP Q1 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AZIYO BIOLOGICS, INC.March 21, 2023576,2534.9%
Oxford Immunotec Global PLCSold outFebruary 17, 202100.0%

View Endurant Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-07
SC 13D/A2024-04-10
13F-HR2024-02-14
13F-HR2023-11-14
SC 13D/A2023-09-08
13F-HR2023-08-14
3/A2023-05-24
13F-HR2023-05-15
32023-05-15
SC 13D2023-05-15

View Endurant Capital Management LP's complete filings history.

Compare quarters

Export Endurant Capital Management LP's holdings